Spanish Red Biotech Pipeline

Gilead Sciences

Magrolimab + chemotherapy/IO combinations

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Head and neck squamous cell carcinoma
Phase: 2Phase II in Spain, 1Phase I in Spain